AmerisourceBergen: stocks, financial statements

Dividends News

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Chesterbrook, PA.

  • ABC Ticker
  • NYSE Exchange
  • 21,000 Employees
2 rated

Financial statements — AmerisourceBergen

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
190B 180B 170B 150B 150B
Cost Of Revenue
180B 170B 160B 150B 140B
Gross Profit
5.2B 5.1B 4.6B 4.5B 4.3B
Research and Development
0 0 0 0 0
Selling General and Admin
2.8B 2.7B 2.5B 2.1B 2.1B
Operating Expense
190B 180B 170B 150B 150B
Operating Income
2B 2B 1.6B 2B 1.8B
Other Income Expense Net
0 0 0 0 0
2B 2B 1.6B 2B 1.8B
Interest Income
140M 160M 170M 150M 140M
Pretax Income
-5.3B 970M 1.2B 920M 1.4B
Income Tax
-1.9B 110M -440M 550M -37M
Minority Interest
9.2M -1.2M -43M 0 0
Net Income
-3.4B 860M 1.7B 360M 1.4B
Net Income Basic
-3.4B 860M 1.7B 360M 1.4B
20 ← 16 2020 2019 2018 2017 2016
Current cash
4.6B 3.4B 2.5B 2.4B 2.7B
Short term investments
1.5B 1.3B 170M 100M 210M
14B 12B 11B 10B 9.2B
13B 11B 12B 11B 11B
Other current assets
1.5B 1.3B 170M 100M 210M
Current assets
33B 28B 26B 24B 23B
Long term investments
11B 11B 12B 11B 11B
Property plant equipment
1.5B 1.8B 1.9B 1.8B 1.5B
6.7B 6.7B 6.7B 6B 6B
Intangible assets
1.9B 2.3B 2.9B 2.8B 3B
Other assets
780M 270M 270M 340M 310M
Total assets
44B 39B 38B 35B 34B
Accounts payable
32B 28B 27B 25B 24B
Current long term debt
500M 140M 150M 12M 610M
Other current liabilities
1.6B 1.1B 880M 1.4B 740M
Total current liabilities
34B 30B 28B 27B 25B
Long term debt
3.6B 4.4B 4.5B 3.8B 3.9B
Other liabilities
7B 380M 410M 160M 160M
Minority Interest
180M 110M 120M 0 0
Total Liabilities
45B 36B 35B 33B 32B
Common stock
200M 210M 220M 220M 210M
Retained earning
520M 4.2B 3.7B 2.4B 2.3B
Treasury stock
-6.5B -6.1B -5.4B -4.8B -4.4B
Capital surplus
Shareholder equity
-1B 2.9B 2.9B 2.1B 2.1B
Net tangible assets
-9.6B -6.1B -6.7B -6.8B -6.8B
20 ← 16 2020 2019 2018 2017 2016
Net Income
-3.4B 860M 1.7B 360M 1.4B
410M 500M 510M 430M 390M
Changes in receivables
1.9B 1.1B 1B 1.1B 950M
Changes in inventories
1.5B -860M 460M 740M 970M
Cash change
1.2B 880M 57M -310M 570M
Cash flow
2.2B 2.3B 1.4B 1.5B 3.2B
Capital expenditures
-370M -310M -340M -470M -460M
Investing activity other
Total investing cash flows
-380M -380M -1.1B -500M -3.2B
Dividends paid
Net borrowings
-2B -190M 2B 1.3B 1.5B
Other financing cash flows
Cash flow financing
-600M -1.1B -240M -1.3B 570M
Exchange rate effect